semaglutide bone mineral density New studies have raised fresh alarms about the popular “weight-loss drug” Ozempic, revealing it may accelerate loss and weaken skeletal health in users. Research published in 2025–2026 shows patients on Once-weekly semaglutide versus placebo in
Description
2024 NEJM) showed semaglutide alone reduced kidney/CV death by 24% in CKD patients
DOI: 10.1056/NEJMe2409972
.png)
The program combines a personal consultant with portioned food, which Jenny Craig believes could help you lose weight
[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Gaspari T, Welungoda I, Widdop RE, Simpson RW, Dear AE
One of the most discussed next generation obesity treatments is Retatrutide, a triple agonist peptide currently being studied for its effects on weight reduction, appetite suppression and metabolic health
